A compound best known for giving almonds and apricots their aroma may be the key to defeating hard-to-kill cancer cells. Japanese researchers found that benzaldehyde can stop the shape-shifting ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease – despite stricter ...

Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease—despite stricter ...

Drug repurposing is undervalued, but it offers potential benefits for patients and healthcare systems, argue Ruth Langley and colleagues Drug repurposing involves finding new indications for ...

Based on these new findings, the National Institute of Health and Care Excellence recommends people with Lynch syndrome ...

Baby aspirin' doses everyday could cut the risk of bowel cancer in half but with fewer side effects for those with a rare ...

Bleeding events occurred substantially less often with the lower dose of aspirin, reported John Burn, MD, of Newcastle ...

Researchers found that clinically achievable doses of curcumin, the active compound in turmeric, target and suppress ...

In a remarkable scientific breakthrough that researchers are calling a ‘eureka moment,’ a team at the University of Cambridge ...

Adjuvant aspirin did not reduce recurrence or improve survival in patients with CRC liver metastases, phase 3 data showed at ...

Too many people are missing out on a potentially life-changing opportunity to prevent cancer,” said Sir John Burn.